Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DG5T9Q
|
|||
| Drug Name |
RTL1000
|
|||
| Indication | Multiple sclerosis [ICD-11: 8A40] | Phase 1 | [1] | |
| Company |
Artielle ImmunoTherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00411723) Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.